AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Acupuncture for ADHD: Acupoint Data Mining, Clinical Effectiveness, and Interviews to Explore Treatment Outcomes.

RecruitingNAAges 6 Years - 12 YearsAllThe Third Affiliated Hospital of Beijing Universi…
💬

In plain words

What the trial is, and whether it could suit you

This study aims to evaluate the efficacy of acupuncture as a treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 6-12 years. Using a mixed-methods approach, the research will triangulate data from acupoint data mining, treatment outcomes assessment, and patient perspectives to provide a comprehensive analysis of acupuncture's potential therapeutic benefits for ADHD. This prospective cohort study will recruit children diagnosed with ADHD, assigning them to receive either acupuncture combined with traditional Chinese herbal treatment or herbal treatment alone. Quantitative assessments using the the SNAP-IV, Conners 3-P, BRIEF-2, PedsQL™ 4.0 Generic Core Scales, PSQI and CGI that will be complemented by qualitative interviews to capture nuanced patient experiences and treatment outcomes. The study will span 12 months, commencing on March 1st, 2025 with an expect

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: Patients will be considered for enrolment if they meet the criteria of: * A confirmed diagnosis of ADHD based on the DSM-5 criteria for ADHD (Western medical diagnosis) and in accordance with the ADHD Chinese Medicine Clinical Trial Design and Evaluation Technical Guidelines. * Aged between 6 and 12 years. * No use of any other pharmacological treatments (both Western and traditional Chinese medicine) within the two weeks prior to the start of the study. * An IQ score of greater than 80, as determined by the Raven's Progressive Matrices test. * The participant has not participated in any other clinical trials. Exclusion Criteria: Patients will be excluded from the study if they meet any of the following criteria: * Do not meet the inclusion criteria * Have comorbid psychiatric disorders, severe medical or psychiatric conditions that may interfere with the study (e.g., epilepsy, severe anxiety), pervasive developmental disorders, intellectual disability, or a history of suicidal or self-harming behavior * Have participated in any other drug clinical trials within the past 3 months. * Have severe comorbid conditions such as cardiovascular, hepatic, renal, or hematologic diseases. * Have any other conditions that the researchers believe may interfere with the assessment of treatment efficacy or safety.
💊

What it tests

  • Chinese herbal medicine
  • Acupuncture
📍

Where

1 site
Pediatrics Outpatient Department of the Third Affiliated Hospital of Beijing University of Chinese Medicine
Beijing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy